Clinical Trials Sponsored by Qun Zhao

Total 4288 results

Sun Yat-sen University

Completed

Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer (SYSUCC-002)

Breast Cancer

China
Sun Yat-sen University

Completed

A Retrospective Cohort Study: Influence of MTHFR C677T and A1298C Polymorphisms on the Survival of Pediatric Patients With Non-Hodgkin's Lymphoma

Pediatric Non-Hodgkin Lymphoma

China
Sun Yat-sen University

Completed

Longitudinal Changes in Refractive Error After Primary IOL Implantation Among Children With Congenital Cataract

Cataract

China
Sun Yat-sen University

Unknown

Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma

China
Sun Yat-sen University

Withdrawn

Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

China
Sun Yat-sen University

Completed

Reducing Eye Strain and Anxiety Using a Digital Intervention During Online Learning Class Recess Among Children at Home: A Randomized Controlled Trial (RESILIENT)

Anxiety | Digital Eye Strain

China
Sun Yat-sen University

Unknown

Correlation Between Refraction and Biometric Parameters

Refractive Errors

China
Sun Yat-sen University

Completed

China Red Eye Study (CRES)

Red Eye

China
Sun Yat-sen University

Completed

FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer (FOCULM)

Metastatic Colorectal Cancer

China
Sun Yat-sen University

Unknown

Artificial Intelligence System for Assessing Image Quality of Slit-Lamp Images and Its Effects on Diagnosis

Artificial Intelligence | Anterior Segment Disorders

China
Chong Kun Dang Pharmaceutical

Completed

The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy (TENUVA-BP)

Hypertension

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers

Benign Prostatic Hyperplasia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal

Benign Prostatic Hyperplasia

Korea, Republic of
Sun Yat-sen University

Completed

Diagnostic Efficacy of CNN in Differentiation of Visual Field

Diagnositic Efficacy of Deep Convolutional Neural Network in Differentiation of Glaucoma Visual Field From Non-glaucoma Visual Field

China
Sun Yat-sen University

Unknown

The Gene Profiles of Primary and Heterogeneous Metastases of Colorectal Cancer

Metastatic Colorectal Cancer

China
Sun Yat-sen University

Unknown

Eye Movement and Cognitive Dysfunction (EMCD)

Cognitive Dysfunction | Eye Movement Disorder
Sun Yat-sen University

Unknown

Evaluation of Somatic Mutation Spectrum as Biomarker for Survival Outcome in Chinese CRC

Colorectal Cancer

China
Sun Yat-sen University

Unknown

Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer

Non Small Cell Lung Cancer | Bevacizumab | Brain Metastases | Sintilimab

China
Chong Kun Dang Pharmaceutical

Completed

A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

Rheumatoid Arthritis

Czechia, Georgia, Poland, Russian Federation, Ukraine
Sun Yat-sen University

Completed

A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis

Spondyloarthropathy

China
Sun Yat-sen University

Completed

Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein

Spondyloarthritis

China
Sun Yat-sen University

Completed

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)

IgA Nephropathy

China
Sun Yat-sen University

Unknown

Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT

Hepatocellular Carcinoma

China
Sun Yat-sen University

Unknown

Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC (FL-ALTER)

Lung Cancer, Nonsmall Cell

China
Chong Kun Dang Pharmaceutical

Completed

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

Alzheimer's Disease (AD)

Korea, Republic of
Sun Yat-sen University

Unknown

Real World Study of Immune Checkpoint Inhibitors for Advanced Gastric Cancer

Gastric Cancer

China
Sun Yat-sen University

Completed

Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail

Hepatocellular Carcinoma
Chong Kun Dang Pharmaceutical

Unknown

Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)

Liver Transplant

Korea, Republic of
Sun Yat-sen University

Unknown

The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Hepatocellular Carcinoma

China
Sun Yat-sen University

Completed

Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure

Liver Cancer | Pain Postoperative

China
Sun Yat-sen University

Unknown

The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
Sun Yat-sen University

Unknown

Effect of Using Myopia Prediction Algorithm on Myopia School-aged Children

Myopia

China
Sun Yat-sen University

Unknown

Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Children

China
Sun Yat-sen University

Unknown

Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab (IVRDME)

Diabetic Macular Edema

China
Sun Yat-sen University

Withdrawn

Phase II of Lenvatinib Plus Toripalimab for Advanced HCC

Hepatocellular Carcinoma

China
Chong Kun Dang Pharmaceutical

Unknown

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers

Hypertension | Dyslipidemias

Korea, Republic of
Sun Yat-sen University

Withdrawn

Phase II of Lenvatinib Plus PD-1 Antibody for Advanced HCC

Hepatocellular Carcinoma

China
Sun Yat-sen University

Unknown

Oral Nutritional Supplements Compared With Standard Diet in Postoperative Gastric Cancer Patients With Adjuvant Chemotherapy

Gastric Cancer

China
Sun Yat-sen University

Unknown

Multi-center Clinical Observation of FCVB in Guangdong Province

Eye Injuries | Retina Detachment | Eye Atrophy | Silicone Emulsion

China
Sun Yat-sen University

Withdrawn

Dongguan Eye Study of Schoolchildren and Adolescents（DESSA）

Child Development

China
Sun Yat-sen University

Unknown

Secondary Intraocular Lens Implantation in Pediatric Patients

Congenital Cataract

China
Sun Yat-sen University

Unknown

Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene

Lung Adenocarcinoma

China
Chong Kun Dang Pharmaceutical

Unknown

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults

Type 2 Diabetes Mellitus

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults

Hypertension | Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition

Type 2 Diabetes Mellitus

Korea, Republic of
Sun Yat-sen University

Completed

Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients

Target Volume Delineation | Early-stage Nasopharyngeal Carcinoma | Intensity Modulated Radiation Therapy

China
Sun Yat-sen University

Unknown

Prophylactic or Preemptive Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B Carriers

Colorectal Neoplasms

China
Sun Yat-sen University

Unknown

Effects and Mechanisms of n-3 PUFAs and Irisin on Abnormal Glucose Metabolism After GDM.

Gestational Diabetes Mellitus

China
Chong Kun Dang Pharmaceutical

Completed

Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337

Hyperlipidemias

Korea, Republic of
Sun Yat-sen University

Completed

Postoperative Pain and Discomfort After Orbital Decompression

Pain | Surgery | Anesthesia

China

3

Subscribe